Author

Wouter Beumer

ProQR Therapeutics (Netherlands)ORCID 0000-0003-0291-516XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

Gerard J. PlatenburgiD· 3 shared Janne J. TuruneniD· 2 shared Kalyan Dulla· 2 shared Petra de Bruijn· 2 shared Andrew R. WebsteriD· 1 shared Anita M. van den Hoek· 1 shared Bart Klein· 1 shared Cathaline den Besten· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetics

Gerard J. PlatenburgORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GeneticsMolecular Therapy — Nucleic AcidsPeer-reviewedJul 9, 2026

ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity

Francesco De Chiara, Eva Coll-de la Rubia, Petra de Bruijn…·Gerard J. Platenburg

This study uses RNA editing to target B4GALT1 in mice, reducing lipid levels and coagulation factors without altering gene expression, suggesting potential for cardiovascular disease therapy.

2 citations

mouseproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintAug 12, 2022

Antisense oligonucleotide therapy for the common Stargardt disease type 1-causing variant in ABCA4

Melita Kaltak, Petra de Bruijn, Davide Piccolo…·Jim Swildens

This study demonstrates that antisense oligonucleotides can correct splicing defects in the ABCA4 c.5461-10T>C variant, restoring protein function in retinal organoids.

1 citation

humanexperimental assay

𝕏 PostBluesky

GeneticsMolecular TherapyPeer-reviewedApr 23, 2021

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Kalyan Dulla, Ralph W. N. Slijkerman, Hester C. van Diepen…·Erwin van Wijk

This study demonstrates that QR-421a induces exon 13 skipping in USH2A transcripts, restoring retinal function in zebrafish and non-human primates.

146 citationstop 1%

zebrafishnon-human primate

𝕏 PostBluesky